Advanced Oncotherapy plc (AVO.L)

1.9250 0.0000 (0.00%) As of 04:23PM BST. Market open.

Advanced Oncotherapy plc

143 Harley street
Ground floor
London W1G 6BH
United Kingdom
44 20 3617 8728
https://www.avoplc.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 174

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Michael Jeffrey Sinclair	Executive Chairman	434.42k	N/A	1942
Mr. Nicolas Serandour	CEO & Executive Director	502.96k	N/A	1975
Prof. Stephen Myers OBE	Executive Director	397.72k	N/A	1946
Mr. Ed Lee	COO & President of Europe	N/A	N/A	N/A
Mr. Graham Pughe	Senior Vice-President of Accounting	N/A	N/A	N/A
Ms. Berengere Pons-Chabord	Senior Vice-President of Corporate Finance	N/A	N/A	N/A
Mr. David Navas	Vice President of Investor and Public Relations	N/A	N/A	N/A
Ms. Bridget Biggar	Director of Human Resources	N/A	N/A	N/A
Ms. Donatella Ungaro	Managing Director of ADAM	N/A	N/A	N/A
Ms. Marina Giunta	Head of Physics Group	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Corporate governance

Advanced Oncotherapy plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.